✦ LIBER ✦

Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection

✍ Scribed by Yair Lotan; Shahrokh F. Shariat; the NMP22 Study Group

Book ID: 109053862
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 101
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.07473.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of clinical factors, including a

Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection

✍ Yair Lotan; Umberto Capitanio; Shahrokh F. Shariat; Georg C. Hutterer; Pierre I. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Evaluation of nuclear matrix protein 22

Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer

✍ Ömer Öge; Necmettin Atsü; Sezer Kendi; Haluk Özen 📂 Article 📅 2001 🏛 Springer Netherlands 🌐 English ⚖ 61 KB

The role of nuclear matrix protein 22 in

The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder

✍ Scott W. Shelfo; Mark S. Soloway 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 467 KB

Urinary cytology and nuclear matrix prot

Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma

✍ Georg C. Hutterer; Pierre I. Karakiewicz; Craig Zippe; Gerson Lüdecke; Hans Boma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Urinary nuclear matrix protein 22 (NMP22

Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

✍ Jonathan H. Hughes; Ruth L. Katz; Julio Rodriguez-Villanueva; Larry Kidd; Colin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

This study compares urine nuclear matrix protein 22 (NMP22) immunoassay and conventional urine cytologic examination for detecting recurrent transitional-cell carcinoma (TCC) of the urinary bladder. One hundred twenty-eight urine specimens from 107 patients with a history of TCC of the urinary bladd

The clinical utility of atypical cytolog

The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22

✍ Rupesh Raina; Geetu Pahlajani; Lee E. Ponsky; Ashok Agarwal; Craig D. Zippe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB